The American Journal of Digestive Diseases

, Volume 4, Issue 2, pp 117–124 | Cite as

Reserpine, gastric secretion, and peptic ulcer

  • William H. Bachrach

Summary and conclusions

1. Single, orally administered doses (0.25 mg. to 0.5 mg.) of reserpine such as are used in the management of hypertension, stimulate HCl secretion only mildly; this effect is prevented by simultaneous administration of a therapeutic dose of an anticholinergic drug. Prolonged therapy with reserpine in these doses does not lead to gastric hypersecretion.

2. Single large doses of reserpine (1 mg. or more) given orally or parenterally usually provoke an intense and sustained secretion of acid, not prevented by even large doses of anticholinergics. The cumulative effects of these large doses is unknown.

3. The evidence to date does not establish reserpine as an important ulcerogenic agent.


Public Health Hypertension Peptic Ulcer Large Dose Cumulative Effect 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Barrett, W. E.,et al. Effect of reserpine on gastric secretion of the dog.J. Pharmacol. & Exper. Therap. 113:3, 1955.Google Scholar
  2. 2.
    Barrett, W. E., Ruthedge, R. A., andRogie, B. Action of Serpasil on gastrointestinal motility and secretion.Proc. Soc. Exper. Biol. & Med. 13:334, 1954.Google Scholar
  3. 3.
    Beman, F. M., Knoll, H. C., andDelor, C. J. The effect of reserpine on gastric secretion.Clin. Res. Proc. 3:131, 1955.Google Scholar
  4. 4.
    Bom, F., Friderichsen, T., andJensen, A. R. Autonomic action of reserpine (Serpasil) especially toward vago-insulin system.Ugesk. laeger 118:329, 1956.Google Scholar
  5. 5.
    Clark, M. L., andSchneider, E. M. The effect of intravenous reserpine on gastric acidity in man.Gastroenterology 29:877, 1955.PubMedGoogle Scholar
  6. 6.
    Cummins, J. F., andBalfour, D. C., Jr. Effect of Rauwolfia alkaloids on the excretion of uropepsin in the human.J.A.M.A. 161:864, 1956.Google Scholar
  7. 7.
    Denney, J. L., Frasher, W. G., andHoytt, D. D. Clinical evaluation of drug therapy in hypertension.Am. J. M. Sc. 230:169, 1955.PubMedGoogle Scholar
  8. 8.
    Dillon, D., andSwain, J. M. Gastrointestinal hemorrhage as a complication of reserpine administration: Report of two cases.Am. J. Psychiat. 113:462, 1956.PubMedGoogle Scholar
  9. 9.
    Drenick, E. J. Reserpine in peptic ulcer.Am. J. Digest. Dis. N.S. 1:521, 1956.Google Scholar
  10. 10.
    Egdahl, R. H., Richards, J. B., andHume, D. M. Effect of reserpine on adrenocortical function in unanesthetized dogs.Science 123:418, 1956.Google Scholar
  11. 11.
    Haverback, B. J.,et al. Effect of serotonin (5-hydroxytryptamine) and related compounds on gastric secretion and intestinal motility in the dog.Gastroenterology 32:1058, 1957.PubMedGoogle Scholar
  12. 12.
    Haverback, B. J.,et al. The effects of reserpine and chlorpromazine on gastric secretion.Am. J. M. Sc. 230:601, 1955.PubMedGoogle Scholar
  13. 13.
    Hollister, L. E. Hematemesis and melena complicating therapy with rauwolfia alkaloids.Arch. Int. Med. 99:218, 1957.Google Scholar
  14. 14.
    Hollister, L. E. Complications from the use of tranquilizing drugs.New England J. Med. 257:170, 1957.Google Scholar
  15. 15.
    Hollister, L. E.,et al. Treatment of chronic schizophrenic reactions with reserpine.Ann. New York Acad. Sci. 61:92, 1955.Google Scholar
  16. 16.
    Hussar, A. E., andBruno, E. Acute duodenal ulcer associated with reserpine therapy.Gastroenterology 31:500, 1956.PubMedGoogle Scholar
  17. 17.
    Kirsner, J. B., andFord, H. Effect of reserpine upon basal gastric secretion.Arch. Int. Med. 99:390, 1957.Google Scholar
  18. 18.
    Liebowitz, D., andCarbone, J. V. Effect of varying doses of reserpine on gastric secretion.New England J. Med. 257:227, 1957.Google Scholar
  19. 19.
    Plummer, A. J.,et al. Pharmacology of rauwolfia alkaloids, including reserpine.Ann. New York Acad. Sc. 59:8, 1954.Google Scholar
  20. 20.
    Rider, J. A. Effect of prolonged oral administration of reserpine (Reserpoid) on gastric secretion.Proc. Soc. Exper. Biol. & Med. 90:636, 1955.Google Scholar
  21. 21.
    Schneider, E. M., andClark, M. L. Hyperchlorhydria induced by intravenous reserpine: Response to various therapeutic agents.Am. J. Digest. Dis. N.S. 1:22, 1956.Google Scholar
  22. 22.
    Schroeder, H. A., andPerry, H. M. Psychosis apparently produced by reserpine.J.A.M.A. 159:839, 1955.Google Scholar
  23. 23.
    Shay, H., Sun, D. C. H., andGruenstein, M. Effect of serotonin and reserpine on interdigestive gastric secretion in the rat.Fed. Proc. 16(1):118, 1957.Google Scholar
  24. 24.
    Ubillus, R. Effects of reserpine on the digestive tract. Reported in “Foreign Letters,”J.A.M.A. 162:1074, 1956.Google Scholar
  25. 25.
    Wolf, J., andRossman, M. E. Effects of reserpine on gastric secretion.Am. J. Gastroenterol. 25:430, 1956.Google Scholar
  26. 26.
    Wofford, J. D., andCummins, A. J. Hemorrhage from duodenal ulcer during the administration of reserpine.New England J. Med. 255:1193, 1956.Google Scholar
  27. 27.
    St. James, A. T., andRyan, A. J. Reserpine therapy producing massive gastric and duodenal hemorrhage.Connecticut M. J. 21:418, 1957.PubMedGoogle Scholar
  28. 28.
    Hirschowitz, B. I.,et al. Effects of 8-hour intravenous infusions of ACTH and the adrenal cortical steroids in normal man. I. Basal gastric secretions and plasma and urinary pepsinogen.J. Clin. Invest. 36:1171, 1957.PubMedGoogle Scholar
  29. 29.
    Kert, M. Personal communication.Google Scholar

Copyright information

© Paul B. Hoeber, Inc. 1959

Authors and Affiliations

  • William H. Bachrach
    • 1
  1. 1.School of Medicine, and Wadsworth Hospital, VA CenterFrom the University of Southern CaliforniaLos Angeles

Personalised recommendations